ASTRO Journals

By VariousScience

ASTRO Journals episodes

April 16, 2024 Red Journal Podcast May 1, 2024: Prostate and Cervical Brachytherapy – Prevalence, Access, Sequencing, Education
Send us Fan Mail
Editor-in-Chief Sue Yom hosts a British-American conversation about brachytherapy. Guests include Dr. Mahbuba Choudhury, Clinical Oncology Registrar and Stereotactic Radiotherapy Fellow at Imperial College London NHS Trust, and Dr. Imtiaz Ahmed, Consultant Clinical Oncologist and Clinical Lead at Southend University Hospital in the UK, first and supervising authors on this month’s paper, Timing of High-Dose Rate Brachytherapy with External Beam Radiotherapy in Intermediate and High-Risk Localized Prostate Cancer Patients and Its Effects on Toxicity and Quality of Life: A Randomized Controlled Trial, as well as Dr. Akila Viswanathan, Professor and Chair of the Department of Radiation Oncology at Johns Hopkins University, supervising author of two papers publishing together this month, Updated Trends in the Utilization of Brachytherapy in Cervical Cancer in the U.S.: A Surveillance, Epidemiology, and End-Results Study and Updated Trends in Brachytherapy Utilization and Disparities in the United States from 2004 to 2020.
49 min
March 22, 2024 Pneumonitis with 60-72 Gy at 4 Gy
Send us Fan Mail
Editor-in-Chief, Robert Amdur, MD, discusses a paper from the March 2024 issue of PRO: "Dose-Volume Predictors of Radiation Pneumonitis After Thoracic Hypofractionated Radiation Therapy" (Volume 14 Issue 2, PMID 37984711). This paper suggests V5, V20, and Mean Lung Dose values to minimize grade ≥2 pneumonitis when treating lung cancer with the moderate hypofractionation programs of 60 or 72 Gy at 4 Gy per treatment. The values they propose are lower than those stated in consensus group guidelines.
14 min
March 18, 2024 Red Journal Podcast April 1, 2024: MRI, Image Guidance, and Adaptive Radiotherapy - From the Combinatorial Therapies Special Issue
Send us Fan Mail
Sue Yom, our Editor-in-Chief, co-hosts with Dr. Salma Jabbour, Deputy Editor at the Red Journal and Professor, Vice Chair of Clinical Research and Faculty Development, and Clinical Chief of the Department of Radiation Oncology at Rutgers University. Guests include Drs. Amar Kishan, Professor, Vice Chair of Clinical and Translational Research, and Chief of the Genitourinary Oncology Service, and Minsong Cao, Professor, Vice Chair of Academic Mission Development, and Director of the Medical Physics Residency Training Program, who were supervising authors on a new study published this month, Quantifying Intrafraction Motion and the Impact of Gating for Magnetic Resonance Imaging-Guided Stereotactic Radiation therapy for Prostate Cancer: Analysis of the Magnetic Resonance Imaging Arm From the MIRAGE Phase 3 Randomized Trial. We also welcome Dr. Lauren Henke, Associate Professor of Radiation Oncology and Director of Gastrointestinal Radiation Oncology at the University Hospitals, Case Western Reserve University, who authored an editorial this month entitled Undoing the Layers: Magnetic Resonance Imaging/Advanced Image Guidance and Adaptive Radiation Therapy.
59 min
February 28, 2024 Endometrial Cancer Molecular Markers
Send us Fan Mail
Editor-in-Chief, Robert Amdur, MD, discusses using molecular markers to make decisions about adjuvant radiotherapy for Endometrial Cancer. The main references for the podcast are the PROshot article in the January 2024 issue of PRO (2024, Issue 1, January/February) and a Topic Discussion paper currently published online ahead of print with title "Path to Precision: Refining Radiation Therapy Guidelines for Early-Stage Endometrial Cancer Through Incorporation of Primary Tumor Size, Lower Uterine Segment Invasion, and Molecular Markers" (PMID 38048989).
14 min
February 26, 2024 Red Journal Podcast March 15, 2024: Sex and Lymph - Hot Topics in Head and Neck Cancer Survivorship
Send us Fan Mail
Editor-in-Chief Sue Yom hosts Dr. Lachlan McDowell, a consultant Radiation Oncologist at the Princess Alexandra Hospital and the first author of a new paper this month, "A longitudinal study evaluating sexual health outcomes and prioritization in patients undergoing chemoradiation for human papillomavirus-associated oropharyngeal cancer," Dr. Jie Deng, Professor of Nursing, Senior Fellow at the Leonard Davis Institute of Health Economics, and Faculty Director of the Laboratory of Innovative & Translational Nursing Research at the University of Pennsylvania, and Dr. Barbara Murphy, Professor of Medicine, Hematology and Oncology Division Director, and Director of the Pain and Symptom Management Oncology Services at Vanderbilt University. Drs. Deng and Murphy were the first and last authors on a second paper this month, Longitudinal Pattern of Lymphedema and Fibrosis in Patients with Oral Cavity or Oropharyngeal Cancer: A Prospective Study.
1 hr 13 min
February 07, 2024 Red Journal Podcast March 1, 2024: The Evolution of Postprostatectomy CTV Delineation
Send us Fan Mail
Editor-in-Chief Sue Yom co-hosts with Dr. Thomas Zilli, Associate Editor at the Red Journal and Professor and Director of the Department of Radiation Oncology at the Oncology Institute of Southern Switzerland. Dr. Zilli was co author on Prostate Bed Delineation Guidelines for Postoperative Radiation Therapy: On Behalf Of The Francophone Group of Urological Radiation Therapy, published in the April 2021 issue of the Red Journal. Guests include Dr. Alan Dal Pra, Associate Professor and Director of Clinical Research in the Department of Radiation Oncology at the University of Miami, who first authored the ESTRO ACROP 2023 guideline and with colleagues at UCLA has worked on patterns of prostate bed recurrence on PSMA-PET in relation to the RTOG guidelines, as well as Dr. Floor Staal, PhD candidate at the University of Groningen, who is focused on the study of salvage radiotherapy treatment and is coordinator of the PSMA-PET Guided Hypofractionated Salvage Prostate Bed Radiotherapy (or PERYTON) trial. She first authored an article publishing this month, PSMA PET/CT based clinical target volume delineation guideline for postprostatectomy salvage radiation therapy: the PERYTON-Guideline.
58 min
January 26, 2024 Radiopaque Viscous Rectal Spacers With Prostate Radiotherapy
Send us Fan Mail
Editor-in-Chief, Robert Amdur, MD, discusses the issues related to using a rectal spacer with prostate radiotherapy that is both radiopaque and viscous. The foundation of the discussion is a paper published in the 2024 January/February issue of PRO: “Application of a Radiopaque Viscous Hydrogel Spacer for Prostate Cancer Radiation Therapy: A Prospective Phase 2 Study” with PMID 37791943. A related paper “Barrigel Spacer Injection Technique” with PMID 37657504 was also published in the issue of PRO.
21 min
January 12, 2024 Red Journal Podcast February 1, 2024: Breast Cancer Management - Without Surgery
Send us Fan Mail
Editor-in-Chief Sue Yom co-hosts with Dr. Jose Bazan, Red Journal Associate Editor and Associate Professor and Director of Breast Radiation Oncology and Radiation Oncology Quality and Safety at City of Hope. Dr. Bazan first authored an editorial this month, Surgical De-Escalation in Breast Cancer: Qualitative Research Introduces Hope for Patients and Illuminates a Blind Spot within Blinded Studies. Guests include Dr. Alexander Stessin, Associate Professor of Radiation Oncology and Pharmacology at Stony Brook University Medical Center and supervising author on the first article, Utility of Stereotactic Body Radiation Therapy in Establishing Local Control for Invasive Breast Cancer Patients Not Undergoing Definitive Surgery, as well as Dr. Simona Shaitelman, Professor of Radiation Oncology at MD Anderson Cancer Center, and Dr. Henry Kuerer, the Robinson Endowed Distinguished Professor of Surgery and Cancer Research and Executive Director of the MD Anderson Cancer Network Breast programs. Drs. Shaitelman and Kuerer were supervising authors on another article this month, Patient Interest in Exploring Non-Surgical Treatment Approaches for Early Stage Breast Cancer: A Qualitative Study. The group also summarizes a new article from Practical Radiation Oncology, Locoregional Ablative Radiotherapy for Breast Cancer Patients Unsuitable for Surgical Resection.
1 hr 22 min
December 28, 2023 Five Fraction SBRT for Prostate Cancer
Send us Fan Mail
Editor-in-Chief, Robert Amdur, MD, reviews the evidence for treating Low-Intermediate Risk prostate cancer with Ultra Hypofractionated SBRT. This discussion was stimulated by a paper published in the November/December 2023 issue of PRO titled "Long-Term Outcomes of a Prospective Study on Highly Hypofractionated Intensity Modulated Radiation Therapy for Localized Prostate Cancer for 3 Weeks" with PMID 37414247. However, the majority of the podcast will focus on data supporting 5 Fraction SBRT, including the most recent report from the PACE-B trial (Abstract only from the 2023 ASTRO annual Meeting).
Additional Article:
Stereotactic Body Radiation Therapy: A Radiosurgery Society Guide to the Treatment of Localized Prostate Cancer Illustrated by Challenging Cases
13 min
December 27, 2023 Online Adaptive Radiotherapy
Send us Fan Mail
Practical Radiation Oncology associate section editor, Sandra Meyers, PhD of University of California, San Diego, hosts a conversation on online adaptive radiotherapy, or the use of imaging to adapt radiation treatments to the anatomy observed each day. Lauren Henke, MD of University Hospitals Cleveland Medical Center and Bin Cai, PhD of UT Southwestern Medical Center discuss their clinical experience with both cone-beam CT and MR-based online adaptive radiotherapy. Benefits and challenges of online adaptive compared to conventional radiotherapy are discussed, as well as strategies for success when implementing this technologically.
53 min

About ASTRO Journals

From the publisher's feed

Stay current with the latest studies in radiation oncology with free podcasts from the official journals of the American Society for Radiation Oncology (ASTRO). The International Journal of…